Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q6FKP2

Entry ID Method Resolution Chain Position Source
AF-Q6FKP2-F1 Predicted AlphaFoldDB

No variants for Q6FKP2

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q6FKP2

No associated diseases with Q6FKP2

2 regional properties for Q6FKP2

Type Name Position InterPro Accession
domain Zinc finger, CCCH-type 8 - 37 IPR000571
domain Pan3 pseudokinase domain 588 - 714 IPR041332

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
PAN complex A complex that possesses poly(A)-specific ribonuclease activity; catalyzes the message-specific shortening of mRNA poly(A) tails. Contains at least two subunits, known as Pan2p and Pan3p in Saccharomyces.

3 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
metal ion binding Binding to a metal ion.
poly(A) binding Binding to a sequence of adenylyl residues in an RNA molecule, such as the poly(A) tail, a sequence of adenylyl residues at the 3' end of eukaryotic mRNA.

3 GO annotations of biological process

Name Definition
mRNA processing Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.
nuclear-transcribed mRNA poly(A) tail shortening Shortening of the poly(A) tail of a nuclear-transcribed mRNA from full length to an oligo(A) length.
postreplication repair The conversion of DNA-damage induced single-stranded gaps into large molecular weight DNA after replication. Includes pathways that remove replication-blocking lesions in conjunction with DNA replication.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MDKINPDWAR DVPCRNVIIY GFCKKKTEGC PFKHDDDDIA TPTSTPKVAD TVPAPSGVIQ
70 80 90 100 110 120
QPSKISVSSL PSLNSQPSST APTSAPNATA HTGSKSQVPK FNAKASASFT PMSKAADGTQ
130 140 150 160 170 180
ETQAPYLESP VAGSPGPILK AGTPVSFMQP NIYSTTPVPS PASMAMPNVV MPPNDMGSPD
190 200 210 220 230 240
LGLQQQSHMV NLDGSIQQNY QERPNVLMRD SSMPLTMGTS GSRPMLDQQI HSISGLSNTS
250 260 270 280 290 300
GPQPPGLLQS MNGASMDMGL PMNLRYPTIY PPTHSILQYH LYAPDPPPQL EIALKENERT
310 320 330 340 350 360
PRMLFIPNDL REELVKRNLA SLQLFPSGGN LPHIVKDYFG LVPLDFHQRS SVKDRYKKHK
370 380 390 400 410 420
NSLYKVFSNV DGRIYLLRRI HDVNISDPTI ISKTFQKWSK IDSSNVVALK DLFLTTAFGD
430 440 450 460 470 480
SSLGIVYDYY PNATSLYEAH FVNYPTVEVT EDLLWSYAVQ ILNGLREIHN TNGVNIGDLD
490 500 510 520 530 540
CDKIILTGKG RIKISAGAEY DIMNMCCPED NEDDDNEEKL RKRNFVDLGE ILFKLASKMC
550 560 570 580 590 600
NCHGKDVANL AQVSEKLKNL IKSLAFEQLH DYVNVATIIE KYIGLDVVFK VMEAQQTYSE
610 620 630 640 650 660
YAENVLSREL ENGRLFRLIC KLNFIFGRVE NRLDINWSEP GDKFVIVLFY DYVFHQIDPN
670 680 690 700 710
TGKPVTDLTH VLRCLNKLDA GVEENILLVT PDELNTAVVS YKKVKELVDK TFRAMTL